Pharmacologic prevention of aspiration pneumonia: A systematic review

American Journal Geriatric Pharmacotherapy

Volumn 5, Issue 4, 2007, Pages 352-362

  El Solh, Ali A ^a   Saliba, Ranime ^b  

^a ERIE COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CABERGOLINE; CAPSAICIN; CAPTOPRIL; CHLORHEXIDINE; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; ENALAPRIL; FOLIC ACID; LEVODOPA; PERGOLIDE; PERINDOPRIL; PLACEBO; PRAMIPEXOLE; PSYCHOTROPIC AGENT; ROPINIROLE; SUBSTANCE P; THEOPHYLLINE;

ABSENCE OF SIDE EFFECTS; ACUTE KIDNEY FAILURE; ANAPHYLAXIS; ANOREXIA; ARTICLE; ASPIRATION PNEUMONIA; BLEEDING; BURNING SENSATION; CLINICAL TRIAL; COCHRANE LIBRARY; COST EFFECTIVENESS ANALYSIS; COUGHING; DELIRIUM; DIARRHEA; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG POTENTIATION; DRUG WITHDRAWAL; EMBASE; EVIDENCE BASED MEDICINE; GASTROINTESTINAL DISEASE; HEART ARRHYTHMIA; HEART PALPITATION; HEART VALVE REGURGITATION; HUMAN; HYPERKALEMIA; HYPOTENSION; INCIDENCE; INJECTION SITE PAIN; LOW DRUG DOSE; MEDLINE; NAUSEA; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEIZURE; SIDE EFFECT; SWALLOWING; SYSTEMATIC REVIEW; TACHYCARDIA; TREATMENT DURATION;

AGED; AMANTADINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPSAICIN; CONTROLLED CLINICAL TRIALS AS TOPIC; ERGOLINES; HUMANS; PNEUMONIA, ASPIRATION; RISK FACTORS; SENSORY SYSTEM AGENTS; TETRAZOLES; THEOPHYLLINE;

EID: 37549000989     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2007.12.005     Document Type: Article

References (74)

1. Marik P. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 344 (2001) 665-671
2. Nakajoh K., Nakagawa T., Sekizawa K., et al. Relation between incidence of pneumonia and protective reflexes in post-stroke patients with oral or tube feeding. J lntern Med. 247 (2000) 39-42
3. Sekizawa K., Ujiie Y., Itabashi S., et al. Lack of cough reflex in aspiration pneumonia. Lancet 335 (1990) 1228-1229
4. Nakazawa H., Sekizawa K., Ujiie Y., et al. Risk of aspiration pneumonia in the elderly. Chest. 103 (1993) 1636-1637
5. Loeb M., Becker M., Eady A., et al. Interventions to prevent aspiration pneumonia in older adults: A systematic review. J Am Geriatr Soc 51 (2003) 1018-1022
6. Walker A., Robins M., and Weinfeld F. The national survey of stroke. Clinical findings. Stroke. 12 Suppl 1 (1981) I-13-I-44
7. Kobayashi H., Hoshino M., Okayama K., et al. Swallowing and cough reflexes after onset of stroke. Chest. 105 (1994) 1623
8. Doggett D., Tappe K., Mitchell M., et al. Prevention of pneumonia in elderly stroke patients by systematic diagnosis and treatment of dysphagia: An evidence-based comprehensive analysis of the literature. Dysphagia. 16 (2001) 279-295
9. Ely E., and Haponik E. Pneumonia in the elderly. J Thorac Imaging. 6 (1991) 45-61
10. Homer J., Massey E., Riski J., et al. Aspiration following stroke: Clinical correlates and outcome. Neurology. 38 (1988) 1359-1362
11. Moine P., Vercken J., Chevret S., et al., for the French Study Group. Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. for Community-Acquired Pneumonia in the Intensive Care Unit. Chest. 105 (1994) 1487-1495
12. Torres A., Serra-Batlles J., Ferrer A., et al. Severe community acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis. 144 (1991) 312-318
13. Baine W., Yu W., and Summe J. Epidemiologic trends in the hospitalization of elderly Medicare patients for pneumonia 1991-1998. AmJPublic Health. 91 (2001) 1121-1123
14. Yamaya M., Yanai M., Ohrui T., et al. Interventions to prevent pneumonia among older adults. J Am Geriatr Soc. 49 (2001) 85-90
15. Abe S., Ishihara K., and Okuda K. Prevalence of potential respiratory pathogens in the mouths of elderly patients and effects of professional oral care. Arch Gerontol Geriatr. 32 (2001) 45-55
16. Taylor G., Loesche W., and Terpenning M. Impact of oral diseases on systemic health in the elderly: Diabetes mellitus and aspiration pneumonia. J Public Health Dent. 60 (2000) 313-320
17. Limeback H. Implications of oral infections on systemic diseases in institutionalized elderly with a special focus on pneumonia. Ann Periodontol. 3 (1998) 262-275
18. Finucane T., and Bynum J. Use of tube feeding to prevent aspiration pneumonia. [published correction appears in Lancet. 1997;349:364]. Lancet. 348 (1996) 1421-1424
19. Cochrane Collaboration Handbook (updated 9 December 1996). In: The Cochrane Collaboration. The Cochrane Library. Issue 2. In: Mulrow C., and Oxman A. (Eds). Update Software (1996), Oxford, United Kingdom
20. Kobayashi H., Nakagawa T., Sekizawa K., et al. Levodopa and swallowing reflex. Lancet. 348 (1996) 1320-1321
21. Arai T., Sekizawa K., Yoshimi N., et al. Cabergoline and silent aspiration in elderly patients with stroke. J Am Geriatr Soc. 51 (2003) 1815-1816
22. Nakagawa T., Wada H., Sekizawa K., et al. Amantadine and pneumonia. Lancet. 353 (1999) 1157
23. Ebihara T., Sekizawa K., Nakazawa H., and Sasaki H. Capsaicin and swallowing reflex. Lancet. 341 (1993) 432
24. Ebihara T., Takahashi H., Ebihara S., et al. Capsaicin troche for swallowing dysfunction in older people. J Am Geriatr Soc. 53 (2005) 824-828
25. Yamaya M., Yanai M., Ohrui T., et al. Antithrombotic therapy for prevention of pneumonia. J Am Geriatr Soc. 49 (2001) 687-688
26. Sato E., Ohrui T., Matsui T., et al. Folate deficiency and risk of pneumonia in older people. J Am Geriatr Soc. 49 (2001) 1739-1740
27. Ebihara T., Ebihara S., Okazaki T., et al. Theophylline improved swallowing reflex in elderly nursing home patients. J Am Geriatr Soc. 52 (2004) 1787-1788
28. Ohkubo T., Chapman N., Neal B., et al., for the Perindopril Protection Against Recurrent Stroke Study Collaborative Group. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med. 169 (2004) 1041-1045
29. Okaishi K., Morimoto S., Fukuo K., et al. Reduction of risk of pneumonia associated with the use of angiotensin I converting enzyme inhibitors in elderly inpatients. Am J Hypertens. 12 (1999) 778-783
30. Arai T., Sekizawa M., Ohrui T., et al. ACE inhibitors and protection against pneumonia in elderly patients with stroke. Neurology. 64 (2005) 573-574
31. Arai T., Yasuda Y., Toshima S., et al. ACE inhibitors and pneumonia in elderly people. Lancet. 352 (1998) 1937-1938
32. Harada J., and Sekizawa K. Angiotensin-converting enzyme inhibitors and pneumonia in elderly patients with intra-cerebral hemorrhage. J Am GeHatr Soc. 54 (2006) 175-176
33. Teramoto S., and Ouchi Y. ACE inhibitors and prevention of aspiration pneumonia in elderly hypertensives. Lancet. 353 (1999) 843
34. Sekizawa K., Matsui T., Nakagawa T., et al. ACE inhibitors and pneumonia. Lancet. 352 (1998) 1069
35. Arai T., Yasuda Y., Takaya T., et al. ACE inhibitors and symptomless dysphagia. Lancet. 352 (1998) 115-116
36. Arai T., Yoshimi N., Fujiwara H., and Sekizawa K. Serum substance P concentrations and silent aspiration in elderly patients with stroke. Neurology. 61 (2003) 1625-1626
37. Nakayama K., Sekizawa K., and Sasaki H. ACE inhibitor and swallowing reflex. Chest. 113 (1998) 1425
38. He M., Ohrui T., Azumi M., et al. Depressed involuntary swallowing and risk of pneumonia. J Am Geriatr Soc. 52 (2004) 1032-1033
39. Graybiel A., and Ragsdale C. Biochemical anatomy of the striatum. In: Emson P. (Ed). Chemical Neuroanatomy (1983), New York, NY: Raven Press 427-504
40. Lindvall O., and Bjorklund A. Dopamine and norepinephrine containing neuron system: Their anatomy in the rat brain. In: Emson P. (Ed). Chemical Neuroanatomy. (1983), New York, NY, Raven Press 229-255
41. Hornykiewicz O. Dopamine (3-hydroxytryptamine) and brain function. Pharmacol Rev. 18 (1966) 925-964
42. Itoh M., Meguro K., Fujiwara T., et al. Assessment of dopamine metabolism in brain of patients with dementia by means of 18F-fluorodopa and PET. Ann Nucl Med. 8 (1994) 245-251
43. Xu M., Moratalla R., Gold L., et al. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell. 79 (1994) 729-742
44. Zafonte R., Watanabe T., and Mann N. Amantadine: A potential treatment for the minimally conscious state. Brain Inj. 12 (1998) 617-621
45. Wakabayashi K., Takahashi H., Ohama E., and Ikuta F. Tyrosine hydroxylase-immunoreactive intrinsic neurons in Auerbach's and Meissner's plexuses of humans. Neurosci Lett. 96 (1989) 259-263
46. Zimmerman R., Ruben F., and Ahwesh E. Influenza, influenza vaccine, and amantadine/rimantadine. J Faro Pract. 45 (1997) 107-122
47. Schade R., Andersolm F., Suissa S., et al. Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med. 356 (2007) 29-38
48. Kikawada M., Iwamoto T., and Takasaki M. Aspiration and infection in the elderly: Epidemiology, diagnosis and management. Drugs Aging. 22 (2005) 115-130
49. Caterina M., Schumacher M., Tominaga M., et al. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature. 389 (1997) 816-824
50. Bergren D. Capsaicin challenge, reflex bronchocon-striction, and local action of substance P. Am J Physiol. 254 (1988) R845-R852
51. Mason L., Moore R., Derry S., et al. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ. 328 (2004) 991
52. Feinberg M., Knebl J., Tully J., and Segall L. Aspiration and the elderly. Dysphagia 5 (1990) 61-71
53. Nakagawa T., Sekizawa K., Nakajoh K., et al. Silent cerebral infarction: A potential risk for pneumonia in the elderly. J Intern Med. 247 (2000) 255-259
54. Pearson A., and Turner A. Folate-dependent 1-carbon transfer to biogenic amines maintained by methylenetet-rahydrofolate reductase. Nature. 258 (1975) 173-174
55. Fernstrom J. Can nutrient supplements modify brain function?. Am J Clin Nutr. 71 Suppl 6 (2000) 1669S-1675S
56. Surtees R., Heales S., and Bowron A. Association of cerebro-spinal fluid deficiency of 5-methyltetrahydrofolate, but not S-adenosylmethionine, with reduced concentrations of the acid metabolites of 5-hydroxytryptamine and dopamine. Clin Sci (Lond). 86 (1994) 697-702
57. Weir D., and Scott J. Brain function in the elderly: Role of vitamin B12 and folate. Br Med Bull. 55 (1999) 669-682
58. Barnes P. Theophylline: New perspectives for an old drug. Am J Respir Crit Care Med. 167 (2003) 813-818
59. Kostic V., Svetel M., Sternic N., et al. Theophylline increases "on" time in advanced parkinsonian patients. Neurology. 52 (1999) 1916
60. Kanda A., Ebihara S., Arai H., et al. Parkinson's disease and impaired chemosensitivity to hypoxia. Lancet. 356 (2000) 2100
61. Ohta K., Fukuchi Y., Grouse L., et al. A prospective clinical study of theophylline safety in 3810 elderly with asthma or COPD. Respir Med. 98 (2004) 1016-1024
62. Barnes P., Baraniuk J., and Belvisi M. Neuropeptides in the respiratory tract. Part II. Am Rev Respir Dis. 144 (1991) 1391-1399
63. Ichinose M., and Barnes P. The effect of peptidase inhibitors on bradykinin-induced bronchoconstriction in guinea-pigs in vivo. Br J Pharmacol. 101 (1990) 77-80
64. Skidgel R., and Erdös E. Cleavage of peptide bonds by angiotensin I converting enzyme. Agents Actions Suppl. 22 (1987) 289-296
65. Ebihara T., Sekizawa K., Ohrui T., et al. Angiotensin-converting enzyme inhibitor and danazol increase sensitivity of cough reflex in female guinea pigs. Am J Respir Crit Care Med. 153 (1996) 812-819
66. Jin Y., Sekizawa K., Fukushima T., et al. Capsaicin desensitization inhibits swallowing reflex in guinea pigs. Am J Respir Crit Care Med. 149 (1994) 261-263
67. Sekizawa K., Matsui T., Nakagawa T., et al. ACE inhibitors and pneumonia. Lancet. 352 (1998) 1069
68. Kostis J., Shelton B., Gosselin G., et al., for the SOLVD Investigators. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). Am HeartJ. 131 (1996) 350-355
69. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. [published correction appears in Lancet. 2000;356:860]. Lancet. 355 (2000) 253-259
70. Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure. Am J Cardiol. 83 (1999) lA-38A.
71. Ryan T., Antman E., Brooks N., et al. 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 100 (1999) 1016-1030
72. Yusuf S., Sleight P., Pogue J., et al., for the Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. [published corrections appear in N Engl J Med. 2000;342:748 and 1376]. N Engl J Med. 342 (2000) 145-153
73. El-SoN A., Pietrantoni C., Bhat A., et al. Colonization of dental plaques: A reservoir of respiratory pathogens for hospital-acquired pneumonia in institutionalized elders. Chest. 126 (2004) 1575-1582
74. Yoneyama T., Yoshida M., Matsui T., Sasaki H., and for the Oral Care Working Group. Oral care and pneumonia. Lancet. 354 (1999) 515